Establishment of a Novel Glycolysis-related Prognostic Gene Signature for Ovarian Cancer and Its Relationships with Immune Infiltration of the Tumor Microenvironment

Overview

Journal J Transl Med

Publisher Biomed Central

Specialties Biomedical Engineering
General Medicine

Date 2021 Sep 9

PMID 34496868

Citations 25

Authors

Jianlei Bi

Fangfang Bi

Xue Pan

Qing Yang

Affiliations

Soon will be listed here.

Abstract

Background: Glycolysis affects tumor growth, invasion, chemotherapy resistance, and the tumor microenvironment. In this study, we aimed to construct a glycolysis-related prognostic model for ovarian cancer and analyze its relationship with the tumor microenvironment's immune cell infiltration.

Methods: We obtained six glycolysis-related gene sets for gene set enrichment analysis (GSEA). Ovarian cancer data from The Cancer Genome Atlas (TCGA) database and two Gene Expression Omnibus (GEO) datasets were divided into two groups after removing batch effects. We compared the tumor environments' immune components in high-risk and low-risk groups and analyzed the correlation between glycolysis- and immune-related genes. Then, we generated and validated a predictive model for the prognosis of ovarian cancer using the glycolysis-related genes.

Results: Overall, 27/329 glycolytic genes were associated with survival in ovarian cancer, 8 of which showed predictive value. The tumor cell components in the tumor microenvironment did not differ between the high-risk and low-risk groups; however, the immune score differed significantly between groups. In total, 13/24 immune cell types differed between groups, including 10 T cell types and three other immune cell types. Eight glycolysis-related prognostic genes were related to the expression of multiple immune-related genes at varying degrees, suggesting a relationship between glycolysis and immune response.

Conclusions: We identified eight glycolysis-related prognostic genes that effectively predicted survival in ovarian cancer. To a certain extent, the newly identified gene signature was related to the tumor microenvironment, especially immune cell infiltration and immune-related gene expression. These findings provide potential biomarkers and therapeutic targets for ovarian cancer.

Citing Articles

Fan S, Xie X, Wei W, Hua T Phenomics. 2024; 4(4):379-393.

PMID: 39583315 PMC: 11584837. DOI: 10.1007/s43657-024-00163-z.

TCEB2/HIF1A signaling axis promotes chemoresistance in ovarian cancer cells by enhancing glycolysis and angiogenesis.

Deng Z, Li B, Wang W, Xia W, Zhang L, Chen L Eur J Med Res. 2024; 29(1):456.

PMID: 39261917 PMC: 11389485. DOI: 10.1186/s40001-024-02050-9.

Single-cell transcriptome analysis revealed heterogeneity in glycolysis and identified IGF2 as a therapeutic target for ovarian cancer subtypes.

Ji J, Bi F, Zhang X, Zhang Z, Xie Y, Yang Q BMC Cancer. 2024; 24(1):926.

PMID: 39085784 PMC: 11292870. DOI: 10.1186/s12885-024-12688-7.

Establishment of an ovarian cancer exhausted CD8+T cells-related genes model by integrated analysis of scRNA-seq and bulk RNA-seq.

Hua T, Liu D, Zhang X, Li S, Wu J, Zhao Q Eur J Med Res. 2024; 29(1):358.

PMID: 38970067 PMC: 11225302. DOI: 10.1186/s40001-024-01948-8.

Astragaloside IV inhibits cell viability and glycolysis of hepatocellular carcinoma by regulating KAT2A-mediated succinylation of PGAM1.

Zhu Y, Lu F BMC Cancer. 2024; 24(1):682.

PMID: 38835015 PMC: 11151566. DOI: 10.1186/s12885-024-12438-9.

References

Husain Z, Seth P, Sukhatme V . Tumor-derived lactate and myeloid-derived suppressor cells: Linking metabolism to cancer immunology. Oncoimmunology. 2014; 2(11):e26383. PMC: 3881600. DOI: 10.4161/onci.26383. View

Dong C, Yuan T, Wu Y, Wang Y, Fan T, Miriyala S . Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer Cell. 2013; 23(3):316-31. PMC: 3703516. DOI: 10.1016/j.ccr.2013.01.022. View

Liu J, Li S, Feng G, Meng H, Nie S, Sun R . Nine glycolysis-related gene signature predicting the survival of patients with endometrial adenocarcinoma. Cancer Cell Int. 2020; 20:183. PMC: 7247270. DOI: 10.1186/s12935-020-01264-1. View

Luo T, Du Y, Duan J, Liang C, Chen G, Jiang K . Development and Validation of a Scoring System Based on 9 Glycolysis-Related Genes for Prognosis Prediction in Gastric Cancer. Technol Cancer Res Treat. 2020; 19:1533033820971670. PMC: 7658532. DOI: 10.1177/1533033820971670. View

Tian M, Chen X, Li L, Wu H, Zeng D, Wang X . Inhibition of AXL enhances chemosensitivity of human ovarian cancer cells to cisplatin via decreasing glycolysis. Acta Pharmacol Sin. 2020; 42(7):1180-1189. PMC: 8209001. DOI: 10.1038/s41401-020-00546-8. View

Goos J, de Cuba E, Coupe V, Diosdado B, Delis-van Diemen P, Karga C . Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis. Ann Surg. 2015; 263(1):138-45. DOI: 10.1097/SLA.0000000000001109. View

Dong D, Dong Y, Fu J, Lu S, Yuan C, Xia M . Bcl2 inhibitor ABT737 reverses the Warburg effect via the Sirt3-HIF1α axis to promote oxidative stress-induced apoptosis in ovarian cancer cells. Life Sci. 2020; 255:117846. DOI: 10.1016/j.lfs.2020.117846. View

Pandey V, Jung Y, Kang J, Steiner M, Qian P, Banerjee A . Artemin Reduces Sensitivity to Doxorubicin and Paclitaxel in Endometrial Carcinoma Cells through Specific Regulation of CD24. Transl Oncol. 2010; 3(4):218-29. PMC: 2915413. DOI: 10.1593/tlo.09325. View

Rezaie R, Falakian Z, Mazloomzadeh S, Ayati M, Morakabati A, Teimouri Dastjerdan M . While Urine and Plasma Decorin Remain Unchanged in Prostate Cancer, Prostatic Tissue Decorin Has a Prognostic Value. Iran Biomed J. 2020; 24(4):229-35. PMC: 7275814. DOI: 10.29252/ibj.24.4.229. View

10.

Chen B, Tang H, Liu X, Liu P, Yang L, Xie X . miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer. Cancer Lett. 2014; 356(2 Pt B):410-7. DOI: 10.1016/j.canlet.2014.09.028. View

11.

Liang G, Liu J, Zhou X, Lin Z, Chen T, Chen G . Anti-CXCR4 Single-Chain Variable Fragment Antibodies Have Anti-Tumor Activity. Front Oncol. 2021; 10:571194. PMC: 7775505. DOI: 10.3389/fonc.2020.571194. View

12.

Warburg O . On the origin of cancer cells. Science. 1956; 123(3191):309-14. DOI: 10.1126/science.123.3191.309. View

13.

Zhao S, Zhang X, Shi Y, Cheng L, Song T, Wu B . MIEF2 over-expression promotes tumor growth and metastasis through reprogramming of glucose metabolism in ovarian cancer. J Exp Clin Cancer Res. 2020; 39(1):286. PMC: 7737286. DOI: 10.1186/s13046-020-01802-9. View

14.

Maringe C, Walters S, Butler J, Coleman M, Hacker N, Hanna L . Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership. Gynecol Oncol. 2012; 127(1):75-82. DOI: 10.1016/j.ygyno.2012.06.033. View

15.

Chang C, Qiu J, OSullivan D, Buck M, Noguchi T, Curtis J . Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression. Cell. 2015; 162(6):1229-41. PMC: 4864363. DOI: 10.1016/j.cell.2015.08.016. View

16.

Liu M, Pan Q, Xiao R, Yu Y, Lu W, Wang L . A cluster of metabolism-related genes predict prognosis and progression of clear cell renal cell carcinoma. Sci Rep. 2020; 10(1):12949. PMC: 7395775. DOI: 10.1038/s41598-020-67760-6. View

17.

Wicker C, Takiar V, Suganya R, Arnold S, Brill Y, Chen L . Evaluation of antioxidant network proteins as novel prognostic biomarkers for head and neck cancer patients. Oral Oncol. 2020; 111:104949. PMC: 8256620. DOI: 10.1016/j.oraloncology.2020.104949. View

18.

Amini S, Fathi F, Mobalegi J, Sofimajidpour H, Ghadimi T . The expressions of stem cell markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3, Dppa4, and Esrrb in bladder, colon, and prostate cancer, and certain cancer cell lines. Anat Cell Biol. 2014; 47(1):1-11. PMC: 3968261. DOI: 10.5115/acb.2014.47.1.1. View

19.

Han Y, Liu Q, Hou J, Gu Y, Zhang Y, Chen Z . Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression. Cell. 2018; 173(3):634-648.e12. DOI: 10.1016/j.cell.2018.02.061. View

20.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View